A6 TouchCare System Enhancement
Type 1 and Insulin-requiring Type 2 Diabetes
Commercial (Iterative Development)Active
Key Facts
Indication
Type 1 and Insulin-requiring Type 2 Diabetes
Phase
Commercial (Iterative Development)
Status
Active
Company
About Medtrum France
Medtrum France, founded in 2014, is a private medical device company specializing in the development of automated insulin delivery systems for diabetes care. The company's technology platform integrates its proprietary insulin patch pumps with continuous glucose monitoring to create a hybrid closed-loop system aimed at improving glycemic control. Operating from Vienna, Austria, it targets the growing global market for diabetes management technologies, competing against larger, established players by focusing on user-friendly, connected solutions. As a commercial-stage company, it generates revenue through the sale of its medical devices and associated disposables.
View full company profileOther Type 1 and Insulin-requiring Type 2 Diabetes Drugs
| Drug | Company | Phase |
|---|---|---|
| MODD1 Insulin Pump | Modular Medical | Development |